Tumor News and Research

RSS

Post-operative radiation therapy reduces pelvic relapse in high-risk bladder cancer

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new phase III randomized trial.

29 Sep 2025

Proton therapy and IMRT show similar outcomes in head and neck cancer trial

A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low rates of side effects for people with locally advanced oropharyngeal cancer.

29 Sep 2025

Genetic variant linked to liver injury after chemotherapy in colorectal cancer patients

A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients with colorectal cancer that has spread to the liver experience more severe liver damage after chemotherapy.

29 Sep 2025

Small molecule AVJ16 shows promise in targeting lung cancer growth

Researchers have discovered a promising new approach to lung cancer treatment. A small molecule called AVJ16 selectively blocks the cancer-driving protein IGF2BP1, halting tumor growth in preclinical studies and killing cancer cells in patient-derived models—while leaving healthy cells unharmed.

29 Sep 2025

Gene expression test identifies prostate cancer patients who benefit from hormone therapy

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery - the first predictive biomarker in this setting.

29 Sep 2025

Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a radiopharmaceutical drug before targeted radiation, compared with radiation alone.

29 Sep 2025

AI tool accurately distinguishes between glioblastoma and primary central nervous system lymphoma

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments.

29 Sep 2025

Super-resolution imaging unlocks the role of transporter nanoclusters in tumor metabolism

Serine serves as a metabolic nexus in tumors, coordinating one-carbon metabolism, nucleotide synthesis, and redox regulation. In recent years, targeting the serine metabolic pathway, particularly the rate-limiting enzyme PHGDH, has attracted considerable attention as a promising anticancer strategy.

29 Sep 2025

Can roselle help fight inflammation? New review suggests strong potential

A new review highlights the anti-inflammatory potential of Hibiscus sabdariffa (roselle), synthesizing evidence from 25 studies published between 2019 and 2024. Most findings are from preclinical models, but they point to promising roles in cardiovascular, metabolic, neuroprotective, and anticancer health.

28 Sep 2025

UCLA presents advances in radiation therapy at ASTRO 2025

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, including studies on targeted radioactive therapy for recurrent prostate cancer, new approaches to stereotactic body radiation for prostate and head and neck cancers, advances in MRI- and 5DCT-guided imaging for more precise treatments, and innovations in patient-focused cancer education.

26 Sep 2025

Genetic testing guides personalized radiation patients with HPV-positive throat cancer

Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according to Cleveland Clinic research.

26 Sep 2025

Novel treatment disrupts tumor immunosuppression in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%.

26 Sep 2025

New T cell therapy targets CTNNB1 cancer mutation with promising results in animal studies

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung and prostate cancer.

26 Sep 2025

Tumor cells adapt and thrive in damaged parts of the pancreas

Pancreatic cancer is one of the most aggressive cancer types. A new study from Karolinska Institutet, in collaboration with the Department of Pathology at Karolinska University Hospital, shows that tumor cells grow not only in the connective tissue-rich environment typical of the disease, but also in damaged parts of the pancreas where normal tissue is altered.

26 Sep 2025

Daily walnut snacks fail to lower inflammation in adults

Research on daily walnut intake showed no significant effects on inflammatory markers or antioxidant capacity in middle-aged individuals with metabolic risks.

26 Sep 2025

Patient-derived organoids advance cancer therapy and vaccines

Tiny, three-dimensional organoid models are reshaping cancer research by recreating the intricate architecture and diversity of human tumors.

25 Sep 2025

Robotic bronchoscope reaches tiny, hard-to-access lung tumors with high accuracy

A cutting-edge bronchoscope that is guided with the help of a robot can reach very small tumors growing in hard-to-reach parts of the lung, according to results of a gold-standard randomized-controlled trial that will be presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands.

25 Sep 2025

UPR modulators show promise in treating cancer-related bone disease

Previous
1
...
65
66
67
68
69
70
71
...
1367
Next

Tumor News and Research

Post-operative radiation therapy reduces pelvic relapse in high-risk bladder cancer

Proton therapy and IMRT show similar outcomes in head and neck cancer trial

Genetic variant linked to liver injury after chemotherapy in colorectal cancer patients

Small molecule AVJ16 shows promise in targeting lung cancer growth

Gene expression test identifies prostate cancer patients who benefit from hormone therapy

Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients

AI tool accurately distinguishes between glioblastoma and primary central nervous system lymphoma

Super-resolution imaging unlocks the role of transporter nanoclusters in tumor metabolism

Can roselle help fight inflammation? New review suggests strong potential

UCLA presents advances in radiation therapy at ASTRO 2025

Genetic testing guides personalized radiation patients with HPV-positive throat cancer

Novel treatment disrupts tumor immunosuppression in pancreatic cancer

New T cell therapy targets CTNNB1 cancer mutation with promising results in animal studies

Tumor cells adapt and thrive in damaged parts of the pancreas

Daily walnut snacks fail to lower inflammation in adults

Patient-derived organoids advance cancer therapy and vaccines

Robotic bronchoscope reaches tiny, hard-to-access lung tumors with high accuracy

UPR modulators show promise in treating cancer-related bone disease

Targeting TGF-β signaling as a strategy to treat liver fibrosis

Greek yogurt after exercise lowers inflammation more than carbs

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News